Cost‐effectiveness of hysterectomy for benign gynecological conditions: a systematic review

Abstract

The objective of this study was to assess the cost-effectiveness of hysterectomy performed for benign indications. Hysterectomy remains the most common major gynecological operation in the Western world. Rates of hysterectomy have not declined as expected with the introduction of new treatment options. Furthermore, use of laparoscopic techniques varies widely within the Nordic countries. We designed a systematic review in a University Central Hospital. The sample included all published studies regarding the cost-effectiveness of hysterectomy performed for benign indications (n = 1666). Medline, Cochrane Library, PsycINFO, CINAHL, and Nursing databases were searched. Inclusion criteria were the availability of pre- and post-intervention health-related quality of life measures (HRQoL) and data on costs. HRQoL, costs, and cost-effectiveness of treatment were the main outcome measures. Studies (n = 24) focused on treatment of symptomatic fibroids (n = 8), treatment of heavy menstrual bleeding (n = 10), various surgical techniques (n = 5) and the effect of various indications for hysterectomy (n = 2). Follow-up periods varied from 4 months to over 10 years. SF/RAND-36 or EQ-5D measures and societal cost perspective were most commonly used. Only 11 studies used individual patient data. HRQoL following hysterectomy was generally good but costs were high. The cost-effectiveness depended on indication, age, and duration of follow-up. The cost-effectiveness of hysterectomy has been surprisingly poorly studied. Conclusions are difficult to draw due to different study designs, indications, follow-up times, and HRQoL instruments used. Rates of hysterectomy have declined less than expected with the introduction of new treatment modalities. Costs of surgery are high. Laparoscopic hysterectomy seems to be the least cost-effective, although further data from original patient cohorts with long-term follow-up are needed.

Heterogeneity of cost estimates in health economic evaluation research. A systematic review of stress urinary incontinence studies

“…Finally, we did not combine cost estimates to a pooled average. To our knowledge, few health economic studies in the field of gynecology have been published that systematically review cost estimates produced by health economic evaluation research [ 50 ]. Therefore, there is no evidence that studies are consistent at reporting transparently, and transferable cost estimates are scarcely used.…”

A systematic review about costing methodology in robotic surgery: evidence for low quality in most of the studies

“…Previous systematic reviews comparing the cost-effectiveness of Robotic Minimally Invasive Surgery (RMIS) with other surgical modalities found higher costs associated with RMIS. However, the conclusions were based on limited evidence due to heterogeneity in study designs, methodology, and time follow-up after surgery [ 1 – 4 ]. In a recent review, key determinants causing higher costs of RMIS compared to open- and laparoscopic surgery were purchase and maintenance cost of the robot, surgical equipment, and additional costs related to longer operation time.…”

Hysterectomy costs depending on operational technique

“…In an increasingly technologically advanced medicine this is an important advantage. Methods which combine effectiveness with minimal financial burden for the healthcare facilities are the most desirable [6,7]. Data from various centers around the world show that the frequency of using a particular technique varies, depending primarily on operator experience and their training.…”